Dual epigenetic modifiers for cancer therapy
Epigenetic drug discovery is an emerging strategy for the treatment of cancer and other pathologies. Here, we discuss our recent discovery of first-in-class dual reversible inhibitors of the histone methyltransferase activity of G9a/EHMT2 and DNA methyltransferases showing in vivo efficacy in human...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2017-07-01
|
| Serie: | Molecular & Cellular Oncology |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.1080/23723556.2017.1342748 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|